Osteoboost
Reduction of bone loss in postmenopausal women with osteopenia
ApprovedActive
Key Facts
Indication
Reduction of bone loss in postmenopausal women with osteopenia
Phase
Approved
Status
Active
Company
About Bone Health Technologies
Bone Health Technologies has pioneered a novel, non-drug intervention for the large and underserved osteopenia market with its FDA-cleared Osteoboost wearable belt. The device uses targeted, low-intensity vibration therapy—technology inspired by NASA research—to stimulate bone-building cells and has demonstrated an over 80% reduction in spinal bone loss in a 12-month clinical trial. As a commercial-stage private company, it represents a significant innovation in women's musculoskeletal health, offering a preventive treatment option before osteoporosis develops. Its recognition as a TIME Best Invention of 2025 underscores its potential impact.
View full company profile